Ann: CAVATAK anti-cancer activity - US Cancer Con, page-4

re: Ann: CAVATAK anti-cancer activity - US Ca... phMurhpy,

I hadn't had chance to compare data with previous results - but I thought success was higher. So thanks to you 2 posters for confirming.

So its a question of just how representative the batch of patients being used in VLA trials are - compared to average cancer patient - as to assessing general potential of Cavatak.

However, given the number of variables between patients, the 'success" rate is holding up amazingly well - such that optimism must be increasing exponentially with every good result being reported.

On another matter, I was lucky enough to get more shares than I was entitled to.